Overview

Daily Tadalafil in Diabetic ED Patients

Status:
NOT_YET_RECRUITING

Trial end date:
2025-08-30

Target enrollment:

Participant gender:

Summary

This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.

Phase:

Details

Lead Sponsor:

South Valley University